Skip to main content

and
  1. Article

    Open Access

    Erratum: Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

    Correction to: British Journal of Cancer (2008) 99, 1050–1055. doi:10.1038/sj.bjc.6604671 Upon publication of the above manuscript in Volume 99 of BJC, the authors noted a small error in the affiliations of L ...

    L Paré, E Marcuello, A Altés, E del Río, L Sedano, J Salazar in British Journal of Cancer (2009)

  2. Article

    Open Access

    Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

    To determine whether molecular parameters could be partly responsible for resistance or sensitivity to oxaliplatin (OX)-based chemotherapy used as first-line treatment in advanced colorectal cancer (CRC). We s...

    L Paré, E Marcuello, A Altés, E del Río, L Sedano, J Salazar in British Journal of Cancer (2008)